{"entity":{"type":"insider","cik":"0001460207","url":"/insider/0001460207","json_url":"/insider/0001460207.json","name":"InterWest Management Partners X, LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":8,"first":"2012-07-05","last":"2021-11-23","span_basis":"filed_date"},"name_variants":[{"name":"InterWest Management Partners X, LLC","source":"filing","n_filings":8,"first_seen":"2012-07-05","last_seen":"2021-11-23"}],"transactions":[{"id":4588646,"accession":"0001209191-21-066518","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-066518","line_url":"/filing/0001209191-21-066518#line-2","is_derivative":false,"issuer_cik":"0001276600","issuer_name":"Braze, Inc.","issuer_ticker":"BRZE","issuer_name_source":null,"issuer_url":"/issuer/0001276600","owner_cik":null,"owner_name":"NASR KHALED; Desai Keval; InterWest Management Partners X, LLC; Kliman Gilbert H; INTERWEST PARTNERS X LP","owner_display_name":"NASR KHALED","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1130000.0,"shares_display":"1,130,000","price_per_share":61.42,"price_display":"61.42","price_state":"stated","total_value":69404600.0,"total_display":"69,404,600.00","total_whole":"69,404,600","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-19","filed_date":"2021-11-23","scope":"insider"},{"id":5338892,"accession":"0001628280-21-013077","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-21-013077","line_url":"/filing/0001628280-21-013077#line-2","is_derivative":false,"issuer_cik":"0001276600","issuer_name":"Doximity, Inc.","issuer_ticker":"DOCS","issuer_name_source":null,"issuer_url":"/issuer/0001276600","owner_cik":null,"owner_name":"InterWest Management Partners X, LLC; NASR KHALED; INTERWEST PARTNERS X LP; Desai Keval","owner_display_name":"InterWest Management Partners X, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4289250.0,"shares_display":"4,289,250","price_per_share":24.57,"price_display":"24.57","price_state":"stated","total_value":105386872.5,"total_display":"105,386,872.50","total_whole":"105,386,873","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-28","filed_date":"2021-06-28","scope":"insider"},{"id":9271260,"accession":"0001209191-20-053342","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-053342","line_url":"/filing/0001209191-20-053342#line-1","is_derivative":false,"issuer_cik":"0001276600","issuer_name":"PMV Pharmaceuticals, Inc.","issuer_ticker":"PMVP","issuer_name_source":null,"issuer_url":"/issuer/0001276600","owner_cik":null,"owner_name":"Desai Keval; INTERWEST PARTNERS X LP; InterWest Management Partners X, LLC; Kliman Gilbert H; NASR KHALED","owner_display_name":"Desai Keval","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":55555.0,"shares_display":"55,555","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":999990.0,"total_display":"999,990.00","total_whole":"999,990","shares_owned_after":55555.0,"shares_owned_after_display":"55,555","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-25","filed_date":"2020-10-02","scope":"insider"},{"id":2294264,"accession":"0001209191-20-052335","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-052335","line_url":"/filing/0001209191-20-052335#line-1","is_derivative":false,"issuer_cik":"0001276600","issuer_name":"PMV Pharmaceuticals, Inc.","issuer_ticker":"PMVP","issuer_name_source":null,"issuer_url":"/issuer/0001276600","owner_cik":null,"owner_name":"INTERWEST PARTNERS X LP; Kliman Gilbert H; NASR KHALED; InterWest Management Partners X, LLC; Desai Keval","owner_display_name":"INTERWEST PARTNERS X LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Commonn Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":55000.0,"shares_display":"55,000","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":990000.0,"total_display":"990,000.00","total_whole":"990,000","shares_owned_after":55000.0,"shares_owned_after_display":"55,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-25","filed_date":"2020-09-29","scope":"insider"},{"id":8761729,"accession":"0000899243-19-021334","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-021334","line_url":"/filing/0000899243-19-021334#line-1","is_derivative":false,"issuer_cik":"0001207833","issuer_name":"OBALON THERAPEUTICS INC","issuer_ticker":"OBLN","issuer_name_source":null,"issuer_url":"/issuer/0001207833","owner_cik":null,"owner_name":"Desai Keval; InterWest Management Partners X, LLC; Kliman Gilbert H; NASR KHALED; INTERWEST PARTNERS X LP; ORONSKY ARNOLD L","owner_display_name":"Desai Keval","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":100000.0,"total_display":"100,000.00","total_whole":"100,000","shares_owned_after":380224.0,"shares_owned_after_display":"380,224","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-06","filed_date":"2019-08-08","scope":"insider"},{"id":6178745,"accession":"0000899243-18-027169","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-18-027169","line_url":"/filing/0000899243-18-027169","is_derivative":false,"issuer_cik":"0001207833","issuer_name":"Eiger BioPharmaceuticals, Inc.","issuer_ticker":"EIGR","issuer_name_source":null,"issuer_url":"/issuer/0001207833","owner_cik":null,"owner_name":"INTERWEST PARTNERS X LP; InterWest Management Partners X, LLC; ORONSKY ARNOLD L; Desai Keval; NASR KHALED; Kliman Gilbert H","owner_display_name":"INTERWEST PARTNERS X LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":237265.0,"shares_display":"237,265","price_per_share":12.063813984363476,"price_display":"12.06","price_state":"stated","total_value":2862320.825,"total_display":"2,862,320.82","total_whole":"2,862,321","shares_owned_after":1388792.0,"shares_owned_after_display":"1,388,792","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-18","filed_date":"2018-10-22","scope":"insider","n_lines":2},{"id":6343956,"accession":"0000899243-18-023312","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-18-023312","line_url":"/filing/0000899243-18-023312#line-1","is_derivative":false,"issuer_cik":"0001207833","issuer_name":"OBALON THERAPEUTICS INC","issuer_ticker":"OBLN","issuer_name_source":null,"issuer_url":"/issuer/0001207833","owner_cik":null,"owner_name":"NASR KHALED; Kliman Gilbert H; InterWest Management Partners X, LLC; INTERWEST PARTNERS X LP; ORONSKY ARNOLD L; Desai Keval","owner_display_name":"NASR KHALED","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1098901.0,"shares_display":"1,098,901","price_per_share":1.82,"price_display":"1.82","price_state":"stated","total_value":1999999.82,"total_display":"1,999,999.82","total_whole":"2,000,000","shares_owned_after":3552239.0,"shares_owned_after_display":"3,552,239","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-23","filed_date":"2018-08-27","scope":"insider"},{"id":2755349,"accession":"0001209191-12-037463","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-12-037463","line_url":"/filing/0001209191-12-037463#line-2","is_derivative":false,"issuer_cik":"0001276600","issuer_name":"TESARO, Inc.","issuer_ticker":"TSRO","issuer_name_source":null,"issuer_url":"/issuer/0001276600","owner_cik":null,"owner_name":"Desai Keval; NASR KHALED; InterWest Management Partners X, LLC","owner_display_name":"Desai Keval","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":444444.0,"shares_display":"444,444","price_per_share":13.5,"price_display":"13.50","price_state":"stated","total_value":5999994.0,"total_display":"5,999,994.00","total_whole":"5,999,994","shares_owned_after":3071701.0,"shares_owned_after_display":"3,071,701","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-07-03","filed_date":"2012-07-05","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001676238","name":"Braze, Inc.","url":"/issuer/0001676238","role":"Ten percent owner","n_filings":1,"first_seen":"2021-11-23","last_seen":"2021-11-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001516513","name":"Doximity, Inc.","url":"/issuer/0001516513","role":"Ten percent owner","n_filings":1,"first_seen":"2021-06-28","last_seen":"2021-06-28"},{"type":"issuer","type_label":"ISSUER","cik":"0001699382","name":"PMV Pharmaceuticals, Inc.","url":"/issuer/0001699382","role":"Ten percent owner","n_filings":2,"first_seen":"2020-09-29","last_seen":"2020-10-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001427570","name":"OBALON THERAPEUTICS INC","url":"/issuer/0001427570","role":"Ten percent owner","n_filings":2,"first_seen":"2018-08-27","last_seen":"2019-08-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001305253","name":"Eiger BioPharmaceuticals, Inc.","url":"/issuer/0001305253","role":"Ten percent owner","n_filings":1,"first_seen":"2018-10-22","last_seen":"2018-10-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001491576","name":"TESARO, Inc.","url":"/issuer/0001491576","role":"Ten percent owner","n_filings":1,"first_seen":"2012-07-05","last_seen":"2012-07-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001460207","retrieved_at":"2026-08-22T21:45:10+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}